| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |